774 related articles for article (PubMed ID: 10733894)
21. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
22. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.
Patra AK; Mukhopadhyay R; Mukhija R; Krishnan A; Garg LC; Panda AK
Protein Expr Purif; 2000 Mar; 18(2):182-92. PubMed ID: 10686149
[TBL] [Abstract][Full Text] [Related]
23. On-column refolding of recombinant human interleukin-4 from inclusion bodies.
Razeghifard MR
Protein Expr Purif; 2004 Sep; 37(1):180-6. PubMed ID: 15294296
[TBL] [Abstract][Full Text] [Related]
24. A simple and efficient method for the purification of membrane-bound levansucrase from Zymomonas mobilis.
Vigants A; Hicke HG; Marx SP
Curr Microbiol; 2001 Jun; 42(6):415-8. PubMed ID: 11381333
[TBL] [Abstract][Full Text] [Related]
25. Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure.
Fradkin AH; Boand CS; Eisenberg SP; Rosendahl MS; Randolph TW
Biotechnol Prog; 2010; 26(3):743-9. PubMed ID: 20196161
[TBL] [Abstract][Full Text] [Related]
26. [Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist].
Li S; Deng X; Zhao H; Huang X; Yu T; Cheng Y; Dan G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1128-32. PubMed ID: 18027711
[TBL] [Abstract][Full Text] [Related]
27. L-cysteine-enhanced renaturation of bioactive soluble tumor necrosis factor ligand family member LIGHT from inclusion bodies in Escherichia coli.
Tsuji I; Mastui H; Ito T; Kurokawa T; Shintani Y
Protein Expr Purif; 2011 Dec; 80(2):239-45. PubMed ID: 21745574
[TBL] [Abstract][Full Text] [Related]
28. Purification, refolding, and characterization of recombinant LHRH-T multimer.
Raina K; Panda AK; Ali MM; Talwar GP
Protein Expr Purif; 2004 Sep; 37(1):8-17. PubMed ID: 15294275
[TBL] [Abstract][Full Text] [Related]
29. Renaturation of recombinant ErmSF and its refolding behavior.
Lee HJ; Jin HJ
Mol Cells; 2003 Oct; 16(2):187-93. PubMed ID: 14651260
[TBL] [Abstract][Full Text] [Related]
30. On-column refolding purification of DT389-hIL13 recombinant protein expressed in Escherichia coli.
Sun W; Dai X; Zheng Y; Wang J; Hou L; Du J; Hu HG
Protein Expr Purif; 2011 Jan; 75(1):83-8. PubMed ID: 20851185
[TBL] [Abstract][Full Text] [Related]
31. On-column refolding and purification of transglutaminase from Streptomyces fradiae expressed as inclusion bodies in Escherichia coli.
Liu XQ; Yang XQ; Xie FH; Song LY; Zhang GQ; Qian SJ
Protein Expr Purif; 2007 Feb; 51(2):179-86. PubMed ID: 16935525
[TBL] [Abstract][Full Text] [Related]
32. A screening system for the identification of refolding conditions for a model protein kinase, p38alpha.
Cowan RH; Davies RA; Pinheiro TT
Anal Biochem; 2008 May; 376(1):25-38. PubMed ID: 18294951
[TBL] [Abstract][Full Text] [Related]
33. [Studies on the expression, purification and renaturation of recombinant N-acety-L-ornithine deacetylase].
Li H; Chen Y; Weng QP; Wu MG; Wei P; Ouyang PK
Sheng Wu Gong Cheng Xue Bao; 2007 May; 23(3):487-92. PubMed ID: 17577999
[TBL] [Abstract][Full Text] [Related]
34. Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2.
Sijwali PS; Brinen LS; Rosenthal PJ
Protein Expr Purif; 2001 Jun; 22(1):128-34. PubMed ID: 11388810
[TBL] [Abstract][Full Text] [Related]
35. Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies.
Gu Z; Weidenhaupt M; Ivanova N; Pavlov M; Xu B; Su ZG; Janson JC
Protein Expr Purif; 2002 Jun; 25(1):174-9. PubMed ID: 12071713
[TBL] [Abstract][Full Text] [Related]
36. Matrix-assisted refolding of oligomeric small heat-shock protein Hsp26.
Franzmann TM
Int J Biol Macromol; 2006 Aug; 39(1-3):104-10. PubMed ID: 16626802
[TBL] [Abstract][Full Text] [Related]
37. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
Misawa S; Kumagai I
Biopolymers; 1999; 51(4):297-307. PubMed ID: 10618597
[TBL] [Abstract][Full Text] [Related]
38. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
39. [Optimization of induction and purification of HIV-1 Gag protein in Escherichia coli expression system].
Fu J; Sun J; Chen P; Huo Z; Hao Y; Liu Y
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1306-11. PubMed ID: 18837413
[TBL] [Abstract][Full Text] [Related]
40. Production and purification of refolded recombinant Plasmodium falciparum beta-ketoacyl-ACP reductase from inclusion bodies.
Karmodiya K; Srivastav RK; Surolia N
Protein Expr Purif; 2005 Jul; 42(1):131-6. PubMed ID: 15939298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
